The role of neoadjuvant chemotherapy in advanced ovarian cancer: The right treatment to the right patient - Ensuring optimal outcomes in advanced ovarian cancer

被引：2
|
作者：
Armbrust, Robert [1 ]
Fotopoulou, Christina [1 ,2 ,3 ]
Sehouli, Jalid [1 ]
机构：
[1] Charite Univ Med Berlin, Virchow Campus Clin, Ctr Oncol Surg, Dept Gynecol, Augustenburger Pl, D-10117 Berlin, Germany
[2] Imperial Coll London, Fac Med, Dept Surg & Canc, London, England
[3] Hammersmith Hosp, London, England
来源：
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 2024年 / 131卷 / 11期
关键词：
D O I：
10.1111/1471-0528.17707
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：1573 / 1574
页数：2
相关论文
共 50 条
  • [41] Neoadjuvant chemotherapy in advanced epithelial ovarian cancer: A survival study
    Baruah, Upasana
    Barmon, Debabrata
    Kataki, Amal Chandra
    Deka, Pankaj
    Hazarika, Munlima
    Saikia, Bhargab J.
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2015, 36 (01) : 38 - 42
  • [42] Neoadjuvant Chemotherapy or Primary Surgery in Advanced Ovarian Cancer REPLY
    Vergote, Ignace
    Coens, Corneel
    Casado, Antonio
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (24): : 2372 - 2372
  • [43] Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer : A Retrospective Study
    Sharma, Shekhar
    Vijaykumar, D. K.
    Chitrathara, K.
    Haji, Altaf Gauhar
    George, Robin C.
    Pavithran, K.
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2007, 28 (01) : 7 - 13
  • [44] EVALUATING THE BENEFITS OF NEOADJUVANT CHEMOTHERAPY FOR ADVANCED EPITHELIAL OVARIAN CANCER
    Gao, Y.
    Li, Y.
    Zhang, C.
    Han, J.
    Liang, H.
    Zhang, K.
    Guo, H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A463 - A464
  • [45] PREDICTORS OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN ADVANCED STAGE OVARIAN CANCER
    Fleming, N.
    Westin, S.
    Coleman, R.
    Soliman, P.
    Fellman, B.
    Meyer, L.
    Shafer, A.
    Rauh-Hain, A.
    Onstad, M.
    Jazaeri, A.
    Sood, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 676 - 676
  • [46] Platinum-based neoadjuvant chemotherapy for advanced ovarian cancer
    Markman, Maurie
    GYNECOLOGIC ONCOLOGY, 2007, 106 (01) : 273 - 274
  • [47] Is Optimal Cytoreduction Post Neoadjuvant Chemotherapy the Only Prognostic Factor in Advanced Ovarian Cancer?
    Dhiman, Pravesh
    Bapsy, P. P.
    Patil, C. N.
    Raghupathi, Renu
    SOUTH ASIAN JOURNAL OF CANCER, 2022, 11 (03) : 207 - 212
  • [48] Should neoadjuvant chemotherapy be preferred to an alternative treatment for advanced ovarian cancer: Comparison of neoadjuvant chemotherapy followed by interval debulking surgery and primary debulking surgery in patients with advanced ovarian cancer
    Liu, J.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 176 - 176
  • [49] Does neoadjuvant chemotherapy increase the risk of worst outcomes in advanced epithelial ovarian cancer?
    Almeida Silva, J.
    Biachi de Castria, T.
    Estevez Diz, M. D. P.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S547 - S547
  • [50] Advanced ovarian cancer: the role of hyperthermic intraperitoneal chemotherapy
    Filippeschi, M.
    Roviello, F.
    Pinto, E.
    Marrelli, D.
    Fiorentini, G.
    Moncini, I.
    Florio, P.
    GIORNALE ITALIANO DI OSTETRICIA E GINECOLOGIA, 2011, 33 (05): : 271 - 277
12345